We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Danaher
DHR
$137B
| $32.3M | 0.3% |
129,308
-13,338
| -9% | -$3.25M |
|
102
Zoetis
ZTS
$31.9B
| $32.2M | 0.3% |
+190,230
| New | +$35.6M |
|
103
Chipotle Mexican Grill
CMG
$42.8B
| $31.9M | 0.29% |
548,050
+242,050
| +79% | +$12.4M |
|
|
X
104
PUT
DELISTED
US Steel
X
| $31.6M | 0.29% |
775,000
+575,000
| +288% | +$26.3M |
|
105
Celldex Therapeutics
CLDX
$3.07B
| $31.5M | 0.29% |
751,060
+363,408
| +94% | +$14.9M |
|
106
Cigna
CI
$72.4B
| $31.5M | 0.29% |
86,658
+42,956
| +98% | +$14.1M |
|
|
DFS
107
DELISTED
Discover Financial Services
DFS
| $31.3M | 0.29% |
238,749
+235,021
| +6,304% | +$26.9M |
|
108
Pfizer
PFE
$145B
| $31.2M | 0.29% |
1,124,721
-366,317
| -25% | -$10.2M |
|
109
Service Corp International
SCI
$11.7B
| $31.1M | 0.29% |
419,738
+157,455
| +60% | +$11.1M |
|
110
DexCom
DXCM
$32.8B
| $30.9M | 0.28% |
222,794
-9,594
| -4% | -$1.21M |
|
111
Arcturus Therapeutics
ARCT
$177M
| $30.9M | 0.28% |
914,364
-155,450
| -15% | -$5.51M |
|
112
Murphy Oil
MUR
$5.5B
| $30.3M | 0.28% |
662,034
-926,709
| -58% | -$37.4M |
|
|
MRUS
113
DELISTED
Merus
MRUS
| $30.2M | 0.28% |
670,799
+427,570
| +176% | +$17.3M |
|
114
Elevance Health
ELV
$82B
| $29.9M | 0.27% |
+57,586
| New | +$28.6M |
|
115
Ascendis Pharma A/S
ASND
$16B
| $29.6M | 0.27% |
196,030
+179,881
| +1,114% | +$25.7M |
|
116
Alkermes
ALKS
$8.33B
| $29M | 0.27% |
1,069,840
-100,849
| -9% | -$2.86M |
|
117
Axsome Therapeutics
AXSM
$10.9B
| $28.7M | 0.26% |
360,128
-202,035
| -36% | -$17M |
|
118
Seagate
STX
$192B
| $28.7M | 0.26% |
308,517
+180,515
| +141% | +$15.9M |
|
119
Lyft
LYFT
$6.35B
| $28.6M | 0.26% |
+1,475,761
| New | +$22.6M |
|
|
CYBR
120
DELISTED
CyberArk
CYBR
| $28.4M | 0.26% |
106,843
+69,280
| +184% | +$17.2M |
|
121
Align Technology
ALGN
$12.4B
| $28.4M | 0.26% |
86,495
+30,723
| +55% | +$9.01M |
|
122
Chord Energy
CHRD
$7.71B
| $27.8M | 0.26% |
+156,186
| New | +$25.1M |
|
123
CAVA Group
CAVA
$7.39B
| $27.5M | 0.25% |
392,121
+2,078
| +0.5% | +$111K |
|
124
Voya Financial
VOYA
$9.13B
| $27.4M | 0.25% |
+371,119
| New | +$26.2M |
|
125
New York Times
NYT
$12.2B
| $27.3M | 0.25% |
632,381
+271,130
| +75% | +$12.3M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.